# The combination of exercise and psychedelics for the treatment of major depressive disorder. > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/combination-exercise-psychedelics-depression/ > **Published:** 2026-03-26T09:01:28-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:38:06-04:00 > **Clinical Summary:** Explore the combination exercise psychedelics depression approach as a potential treatment for major depressive disorder with complementary biological mechanisms. --- CED Clinical Relevance  #58Monitored Relevance  Early-stage or contextual signal requiring further evidence before action. 🔬 Evidence Watch  |  CED Clinic DepressionExercisePsychedelicsBdnfNeuroplasticity Journal Discover mental health Study Type [Clinical Study](https://cedclinic.com/cannabis-hyperemesis-syndrome-psychiatric-risk/) Population Human participants Why This Matters With treatment-resistant depression affecting up to 50% of patients, clinicians need evidence-based combination approaches. This commentary explores the biological rationale for combining exercise with psychedelics, potentially informing future treatment protocols for major depressive disorder. Clinical Summary This is a theoretical commentary examining the potential synergy between exercise and psychedelics for major depressive disorder treatment. The authors propose complementary mechanisms: psychedelics acutely enhance BDNF signaling and cortical neuroplasticity, while exercise provides sustained BDNF elevation and hippocampal neurogenesis. The commentary suggests these interventions target different but complementary neural pathways involved in depression recovery. However, this represents theoretical framework rather than clinical trial data. Dr. Caplan’s Take “While the biological rationale is compelling, I remain cautious about combination recommendations without controlled trial data. The mechanistic overlap between exercise and psychedelics is intriguing, but we need safety and efficacy studies before clinical implementation.” Clinical Perspective 🧠 Clinicians should continue recommending exercise as evidence-based adjunctive therapy for depression. For patients considering psychedelic therapy, discussing exercise as a complementary intervention may be reasonable, but combination protocols require further research before routine clinical application. 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just%20read%20this%20on%20CEDclinic.com%3A%20The%20combination%20of%20exercise%20and%20psychedelics%20for%20the%20treatment%20of%20major%20depressi...%20%40drcaplan&url=https%3A//pubmed.ncbi.nlm.nih.gov/41793582/)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=https%3A//pubmed.ncbi.nlm.nih.gov/41793582/)[🦥 Share on BlueSky](https://bsky.app/intent/compose?text=Just%20read%20this%3A%20The%20combination%20of%20exercise%20and%20psychedelics%20for%20the%20treatment%20of%20major%20depressi...%20--%20via%20%40drcaplan.bsky.social%20https%3A//pubmed.ncbi.nlm.nih.gov/41793582/)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan/)[📝 Read more on Substack](https://substack.com/@doctorapproved)[🔔 Subscribe via RSS](https://cedclinic.com/category/cannabis-news/feed/) 📰 Source: [https://pubmed.ncbi.nlm.nih.gov/41793582/](https://pubmed.ncbi.nlm.nih.gov/41793582/) Table of Contents - [FAQ](#FAQ)[Could combining exercise with psychedelics be more effective than either treatment alone for depression?](#Could_combining_exercise_with_psychedelics_be_more_effective_than_either_treatment_alone_for_depression) - [What are the different brain mechanisms through which exercise and psychedelics might help depression?](#What_are_the_different_brain_mechanisms_through_which_exercise_and_psychedelics_might_help_depression) - [Is this treatment approach ready for clinical use in patients with treatment-resistant depression?](#Is_this_treatment_approach_ready_for_clinical_use_in_patients_with_treatment-resistant_depression) - [How significant is the treatment gap this combination might address?](#How_significant_is_the_treatment_gap_this_combination_might_address) - [What type of evidence would be needed before considering this combination therapy?](#What_type_of_evidence_would_be_needed_before_considering_this_combination_therapy) - [Related](#Related) ## FAQ #### Could combining exercise with psychedelics be more effective than either treatment alone for depression? This commentary suggests potential synergy between exercise and psychedelics for treating major depressive disorder, as they appear to work through complementary biological mechanisms. However, this is currently theoretical – no [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) have actually tested the combination, so safety and efficacy remain unproven. #### What are the different brain mechanisms through which exercise and psychedelics might help depression? According to the study, psychedelics provide acute BDNF enhancement and increase cortical neuroplasticity, while exercise offers sustained BDNF elevation and boosts hippocampal neurogenesis. Additionally, psychedelics increase glutamate release through 5-HT receptor stimulation, creating potentially complementary pathways for antidepressant effects. #### Is this treatment approach ready for clinical use in patients with treatment-resistant depression? No, this approach is not ready for clinical implementation. The study is a commentary discussing theoretical potential, not clinical trial data, and combining psychedelics with exercise could pose unknown safety risks that require rigorous research. #### How significant is the treatment gap this combination might address? The study notes that over 50% of people with major depressive disorder do not respond to primary treatment modalities, representing a substantial unmet clinical need. This large treatment gap has driven interest in alternative approaches like exercise and psychedelics, though their combination remains investigational. #### What type of evidence would be needed before considering this combination therapy? Controlled [clinical trials](https://cedclinic.com/endocannabinoid-system-emotional-memory-ptsd-treatment/) would be essential to establish safety, dosing protocols, timing of interventions, and efficacy compared to standard treatments. Additionally, research on potential drug interactions, contraindications, and optimal patient selection criteria would be required before clinical application. {“@context”: “https://schema.org”, “@type”: “ScholarlyArticle”, “headline”: “The combination of exercise and psychedelics for the treatment of major depressive disorder.”, “url”: “https://pubmed.ncbi.nlm.nih.gov/41793582/”, “about”: “discover mental health [clinical study](https://cedclinic.com/cannabis-hyperemesis-syndrome-psychiatric-risk/) combination”, “isPartOf”: “Discover mental health”} [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [Lifestyle and Behavioral Enhancements of Sleep: A Review.](https://cedclinic.com/sleep-hygiene-cbt-i-lifestyle-enhancements/) Explore how lifestyle and behavioral changes can improve sleep quality, an important factor in mental health and depression management. [Read More](https://cedclinic.com/sleep-hygiene-cbt-i-lifestyle-enhancements/) [Cannabinoid Effects of Metamizol/Dipyrone: A Possible Second Life in Pediatric Anesthesia for a Vintage Drug.](https://cedclinic.com/metamizol-pediatric-anesthesia-cannabinoid-effects/) Review cannabinoid interactions with traditional drugs, highlighting emerging therapeutic potentials relevant to mental health. [Explore Article](https://cedclinic.com/metamizol-pediatric-anesthesia-cannabinoid-effects/) [Cannabis Use Disorder Treatment Europe Review](https://cedclinic.com/cannabis-use-disorder-treatment-europe-evidence-watch/) An evidence-based review of [cannabis use disorder](https://cedclinic.com/sex-differences-cannabis-stress-reactivity-oxytocin/) treatments in Europe, relevant for understanding [substance use](https://cedclinic.com/stroke-risk-assessment-substance-use/) in mental health contexts. [Learn More](https://cedclinic.com/cannabis-use-disorder-treatment-europe-evidence-watch/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).